Gilead Sciences (GILD)

Company Ticker Sector | Industry Quality PAR
Gilead Sciences GILD Healthcare | Biotechnology 69 8.2%
Current Price (01/16) $67.64
CAPS Rating (Rate this stock on CAPS) Foolcaps 5
Expected Income Statement
Current Sales 21,639.2
Sales Growth Forecast 2.0%
Net Profit Margin 36.0%
Projected Shares Outstanding 1,279.70
EPS - Five year Forecast $6.72
Average P/E Ratio 13.0
Projected Average Price $87.41
Price Appreciation (Annualized) 5.3%
Annual Dividend Yield 2.9%
Projected Annual Return 8.2%
Quality
Financial Strength 95 23.7
EPS Stability 50 12.6
Industry Sales Growth Rate 16.0% 1.6
Industry Net Profit Margin 25.5% 17.6
Calculated Quality Rating 55.4
Fool CAPS

Total Players

3542 Outperforms
89 Underperforms
 

All-Stars (743)

729 Outperforms (98%)
14 Underperforms
 
Fundamental Data Updated: 01/04/2019

MIPAR 9.8%  
Sweet Spot 14.8% - 19.8%  

Top In Biotechnology

Ticker Quality PAR
JAZZ 97 17.7%
CBPO 76 16.1%
UTHR 78 12.2%
REGN 69 13.8%
BIIB 84 9.4%

Top In Healthcare

Ticker Quality PAR
ALGN 99 18.7%
JAZZ 97 17.7%
MD 84 17.5%
CVS 87 16.6%
LMAT 85 17.2%